First Time Loading...

BioCryst Pharmaceuticals Inc
NASDAQ:BCRX

Watchlist Manager
BioCryst Pharmaceuticals Inc Logo
BioCryst Pharmaceuticals Inc
NASDAQ:BCRX
Watchlist
Price: 6.31 USD -5.26% Market Closed
Updated: May 23, 2024

BioCryst Pharmaceuticals Inc
PP&E Gross

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

BioCryst Pharmaceuticals Inc
PP&E Gross Peer Comparison

Comparables:
ABBV
GILD
AMGN
VRTX
REGN

Competitive PP&E Gross Analysis
Latest Figures & CAGR of Competitors

Company PP&E Gross CAGR 3Y CAGR 5Y CAGR 10Y
BioCryst Pharmaceuticals Inc
NASDAQ:BCRX
PP&E Gross
$20.7m
CAGR 3-Years
25%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Abbvie Inc
NYSE:ABBV
PP&E Gross
$5B
CAGR 3-Years
-1%
CAGR 5-Years
9%
CAGR 10-Years
8%
Gilead Sciences Inc
NASDAQ:GILD
PP&E Gross
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Amgen Inc
NASDAQ:AMGN
PP&E Gross
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
PP&E Gross
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
PP&E Gross
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is BioCryst Pharmaceuticals Inc's PP&E Gross?
PP&E Gross
20.7m USD

Based on the financial report for Mar 31, 2024, BioCryst Pharmaceuticals Inc's PP&E Gross amounts to 20.7m USD.

What is BioCryst Pharmaceuticals Inc's PP&E Gross growth rate?
PP&E Gross CAGR 3Y
25%

Over the last year, the PP&E Gross growth was 35%. The average annual PP&E Gross growth rates for BioCryst Pharmaceuticals Inc have been 25% over the past three years .